To own Healthcare Realty Trust, an investor needs to be comfortable with a real estate platform that is still reporting losses but is leaning on stable outpatient medical demand and its HR 2.0 model to support occupancy and rent. The latest quarter showed revenue of US$286.64 million and a net loss of US$15.76 million, which means the story still hinges on execution, not clean profitability.
The key short term catalyst remains the firm’s ability to convert its redevelopment, joint venture pipeline, and leasing spreads into higher NOI and FFO while interest costs stay manageable. The main risk sits around capital intensity and financing, because elevated tenant improvements and future refinancing needs could keep earnings under pressure even if operational metrics hold up.
The most relevant piece of news for that thesis is the fresh US$500 million share repurchase authorization that runs to October 25, 2027. Management has already completed US$149.84 million of buybacks under the prior plan, retiring 2.44% of shares, which reflects a willingness to return capital even while reporting losses.
For you as a shareholder, the new Healthcare Realty Trust program matters because it interacts directly with the operating backdrop. If the HR 2.0 operating model, redevelopment yields, and joint ventures deliver the cash flow analysts expect, buybacks can reduce the share count and increase any future improvement in per share metrics, while misexecution or higher interest expense would make that capital return choice more demanding on the balance sheet.
Healthcare Realty Trust's narrative projects US$1.2b revenue and US$62.7 million earnings by 2029. This assumes 1.8% yearly revenue growth and an earnings increase of about US$152 million from current earnings of a US$89.6 million loss.
Uncover why Healthcare Realty Trust's fair value indicates an 11% potential upside to its current price that could narrow quickly.
Two fair value estimates from the Simply Wall St Community sit between about US$21.08 and US$32.48 per share, which already shows how far retail opinions on Healthcare Realty Trust can stretch. When you also factor in the affirmed US$0.24 dividend, the new US$500m buyback plan, and ongoing losses, it becomes clear why views can diverge sharply. If you want a fuller picture, compare these community forecasts with your own assessment of refinancing risk, redevelopment outcomes, and sector demand before deciding where you sit in that spectrum.
Explore another Healthcare Realty Trust fair value estimate, including one that suggests it could be worth just $21.08.
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
If you want to stress test your view on Healthcare Realty Trust and build a broader watchlist around it, cast a wider net using the Simply Wall St Screener. Comparing this REIT with other income, quality, and lower risk candidates can sharpen your decision making and help you spot patterns that do not show up when you only focus on a single ticker.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com